US Stock MarketDetailed Quotes

Coya Therapeutics (COYA)

Watchlist
  • 4.320
  • -0.020-0.46%
Close Apr 24 16:00 ET
  • 4.320
  • 0.0000.00%
Post 20:01 ET
101.34MMarket Cap-3.40P/E (TTM)

Coya Therapeutics (COYA) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
22.13%46.82M
22.13%46.82M
-9.43%28.13M
-18.64%29.76M
-1.27%35.53M
17.51%38.34M
17.51%38.34M
185.29%31.06M
179.15%36.58M
120.52%35.99M
-Cash and cash equivalents
22.13%46.82M
22.13%46.82M
-9.43%28.13M
-18.64%29.76M
-1.27%35.53M
17.51%38.34M
17.51%38.34M
185.29%31.06M
179.15%36.58M
120.52%35.99M
Receivables
--0
--0
--0
--0
--0
-90.26%730.58K
-90.26%730.58K
--0
--0
--0
-Taxes receivable
--0
--0
--0
--0
--0
--730.58K
--730.58K
----
----
----
Prepaid assets
-40.51%3.12M
-40.51%3.12M
-12.45%3.89M
10.84%3.67M
111.35%2.84M
389.74%5.24M
389.74%5.24M
--4.45M
--3.31M
--1.34M
Total current assets
12.71%49.94M
12.71%49.94M
-9.81%32.02M
-16.19%33.43M
2.78%38.37M
7.55%44.31M
7.55%44.31M
200.33%35.51M
177.19%39.89M
115.40%37.33M
Non current assets
Net PPE
-70.91%11.23K
-70.91%11.23K
-60.23%18.07K
-52.35%24.91K
-46.29%31.75K
-41.49%38.59K
-41.49%38.59K
-37.59%45.43K
-34.36%52.27K
-31.64%59.11K
-Gross PPE
----
----
----
----
----
0.00%136.8K
0.00%136.8K
----
----
----
-Accumulated depreciation
----
----
----
----
----
-38.62%-98.22K
-38.62%-98.22K
----
----
----
Total non current assets
-70.91%11.23K
-70.91%11.23K
-60.23%18.07K
-52.35%24.91K
-46.29%31.75K
-41.49%38.59K
-41.49%38.59K
-37.59%45.43K
-34.36%52.27K
-31.64%59.11K
Total assets
12.63%49.95M
12.63%49.95M
-9.87%32.04M
-16.24%33.45M
2.71%38.4M
7.48%44.35M
7.48%44.35M
198.87%35.55M
176.02%39.94M
114.67%37.39M
Liabilities
Current liabilities
Payables
-33.18%1.06M
-33.18%1.06M
230.15%1.11M
-50.54%931.34K
-26.90%1.69M
-15.50%1.59M
-15.50%1.59M
-46.89%336.72K
692.61%1.88M
326.73%2.31M
-accounts payable
-33.18%1.06M
-33.18%1.06M
230.15%1.11M
-50.54%931.34K
6.43%1.69M
37.42%1.59M
37.42%1.59M
-46.89%336.72K
692.61%1.88M
193.11%1.59M
-Total tax payable
----
----
----
----
----
--0
--0
--0
--0
--723.85K
Current accrued expenses
160.29%3.61M
160.29%3.61M
16.28%1.64M
182.95%2.84M
37.33%1.81M
-38.29%1.39M
-38.29%1.39M
20.17%1.41M
1.99%1M
81.83%1.32M
Current deferred liabilities
41.21%1.2M
41.21%1.2M
59.96%916.71K
-22.15%731.08K
22.00%841.41K
-8.11%848.29K
-8.11%848.29K
--573.09K
--939.04K
--689.67K
Current liabilities
53.53%5.87M
53.53%5.87M
58.13%3.67M
17.66%4.5M
0.51%4.34M
-24.30%3.82M
-24.30%3.82M
28.36%2.32M
213.24%3.83M
241.05%4.32M
Non current liabilities
Non current deferred liabilities
11.07%1.05M
11.07%1.05M
-10.74%1.09M
-25.16%641.16K
1.93%694.44K
64.52%945.45K
64.52%945.45K
--1.22M
--856.65K
--681.29K
Total non current liabilities
11.07%1.05M
11.07%1.05M
-10.74%1.09M
-25.16%641.16K
1.93%694.44K
64.52%945.45K
64.52%945.45K
--1.22M
--856.65K
--681.29K
Total liabilities
45.12%6.92M
45.12%6.92M
34.36%4.76M
9.83%5.14M
0.70%5.04M
-15.23%4.77M
-15.23%4.77M
96.04%3.54M
283.39%4.68M
294.84%5M
Shareholders'equity
Share capital
25.31%2.09K
25.31%2.09K
9.98%1.68K
9.85%1.67K
14.43%1.67K
15.96%1.67K
15.96%1.67K
52.91%1.52K
52.91%1.52K
46.79%1.46K
-common stock
25.31%2.09K
25.31%2.09K
9.98%1.68K
9.85%1.67K
14.43%1.67K
15.96%1.67K
15.96%1.67K
52.91%1.52K
52.91%1.52K
46.79%1.46K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-52.11%-61.96M
-52.11%-61.96M
-48.74%-56.25M
-60.17%-54.14M
-55.44%-48.04M
-57.55%-40.74M
-57.55%-40.74M
-39.45%-37.82M
-42.61%-33.8M
-50.00%-30.91M
Paid-in capital
30.73%104.99M
30.73%104.99M
19.63%83.54M
19.39%82.45M
28.31%81.41M
30.59%80.31M
30.59%80.31M
87.66%69.83M
86.90%69.06M
72.62%63.45M
Other equity interest
----
----
----
----
----
----
----
----
----
---149.25K
Total stockholders'equity
8.72%43.03M
8.72%43.03M
-14.76%27.28M
-19.70%28.31M
3.01%33.37M
11.06%39.58M
11.06%39.58M
217.28%32.01M
166.13%35.26M
100.55%32.39M
Total equity
8.72%43.03M
8.72%43.03M
-14.76%27.28M
-19.70%28.31M
3.01%33.37M
11.06%39.58M
11.06%39.58M
217.28%32.01M
166.13%35.26M
100.55%32.39M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments 22.13%46.82M22.13%46.82M-9.43%28.13M-18.64%29.76M-1.27%35.53M17.51%38.34M17.51%38.34M185.29%31.06M179.15%36.58M120.52%35.99M
-Cash and cash equivalents 22.13%46.82M22.13%46.82M-9.43%28.13M-18.64%29.76M-1.27%35.53M17.51%38.34M17.51%38.34M185.29%31.06M179.15%36.58M120.52%35.99M
Receivables --0--0--0--0--0-90.26%730.58K-90.26%730.58K--0--0--0
-Taxes receivable --0--0--0--0--0--730.58K--730.58K------------
Prepaid assets -40.51%3.12M-40.51%3.12M-12.45%3.89M10.84%3.67M111.35%2.84M389.74%5.24M389.74%5.24M--4.45M--3.31M--1.34M
Total current assets 12.71%49.94M12.71%49.94M-9.81%32.02M-16.19%33.43M2.78%38.37M7.55%44.31M7.55%44.31M200.33%35.51M177.19%39.89M115.40%37.33M
Non current assets
Net PPE -70.91%11.23K-70.91%11.23K-60.23%18.07K-52.35%24.91K-46.29%31.75K-41.49%38.59K-41.49%38.59K-37.59%45.43K-34.36%52.27K-31.64%59.11K
-Gross PPE --------------------0.00%136.8K0.00%136.8K------------
-Accumulated depreciation ---------------------38.62%-98.22K-38.62%-98.22K------------
Total non current assets -70.91%11.23K-70.91%11.23K-60.23%18.07K-52.35%24.91K-46.29%31.75K-41.49%38.59K-41.49%38.59K-37.59%45.43K-34.36%52.27K-31.64%59.11K
Total assets 12.63%49.95M12.63%49.95M-9.87%32.04M-16.24%33.45M2.71%38.4M7.48%44.35M7.48%44.35M198.87%35.55M176.02%39.94M114.67%37.39M
Liabilities
Current liabilities
Payables -33.18%1.06M-33.18%1.06M230.15%1.11M-50.54%931.34K-26.90%1.69M-15.50%1.59M-15.50%1.59M-46.89%336.72K692.61%1.88M326.73%2.31M
-accounts payable -33.18%1.06M-33.18%1.06M230.15%1.11M-50.54%931.34K6.43%1.69M37.42%1.59M37.42%1.59M-46.89%336.72K692.61%1.88M193.11%1.59M
-Total tax payable ----------------------0--0--0--0--723.85K
Current accrued expenses 160.29%3.61M160.29%3.61M16.28%1.64M182.95%2.84M37.33%1.81M-38.29%1.39M-38.29%1.39M20.17%1.41M1.99%1M81.83%1.32M
Current deferred liabilities 41.21%1.2M41.21%1.2M59.96%916.71K-22.15%731.08K22.00%841.41K-8.11%848.29K-8.11%848.29K--573.09K--939.04K--689.67K
Current liabilities 53.53%5.87M53.53%5.87M58.13%3.67M17.66%4.5M0.51%4.34M-24.30%3.82M-24.30%3.82M28.36%2.32M213.24%3.83M241.05%4.32M
Non current liabilities
Non current deferred liabilities 11.07%1.05M11.07%1.05M-10.74%1.09M-25.16%641.16K1.93%694.44K64.52%945.45K64.52%945.45K--1.22M--856.65K--681.29K
Total non current liabilities 11.07%1.05M11.07%1.05M-10.74%1.09M-25.16%641.16K1.93%694.44K64.52%945.45K64.52%945.45K--1.22M--856.65K--681.29K
Total liabilities 45.12%6.92M45.12%6.92M34.36%4.76M9.83%5.14M0.70%5.04M-15.23%4.77M-15.23%4.77M96.04%3.54M283.39%4.68M294.84%5M
Shareholders'equity
Share capital 25.31%2.09K25.31%2.09K9.98%1.68K9.85%1.67K14.43%1.67K15.96%1.67K15.96%1.67K52.91%1.52K52.91%1.52K46.79%1.46K
-common stock 25.31%2.09K25.31%2.09K9.98%1.68K9.85%1.67K14.43%1.67K15.96%1.67K15.96%1.67K52.91%1.52K52.91%1.52K46.79%1.46K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -52.11%-61.96M-52.11%-61.96M-48.74%-56.25M-60.17%-54.14M-55.44%-48.04M-57.55%-40.74M-57.55%-40.74M-39.45%-37.82M-42.61%-33.8M-50.00%-30.91M
Paid-in capital 30.73%104.99M30.73%104.99M19.63%83.54M19.39%82.45M28.31%81.41M30.59%80.31M30.59%80.31M87.66%69.83M86.90%69.06M72.62%63.45M
Other equity interest ---------------------------------------149.25K
Total stockholders'equity 8.72%43.03M8.72%43.03M-14.76%27.28M-19.70%28.31M3.01%33.37M11.06%39.58M11.06%39.58M217.28%32.01M166.13%35.26M100.55%32.39M
Total equity 8.72%43.03M8.72%43.03M-14.76%27.28M-19.70%28.31M3.01%33.37M11.06%39.58M11.06%39.58M217.28%32.01M166.13%35.26M100.55%32.39M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More